PRICESYNC
"PRICESYNC" is a word mark owned by Prime Therapeutics LLC, filed at the USPTO on May 1, 2025. It is under examination and covers classes 35, 36 and 44.
- Status
- Under examination
- Since September 4, 2026
- Filed
- May 1, 2025
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 99166742
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 3 classes
Who owns PRICESYNC
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Prime Therapeutics LLC
Eagan, United States
Representative
Felicia J. Boyd
Norton Rose Fulbright US LLP
What the mark covers
The products and services PRICESYNC is filed for, grouped by Nice class.
Pharmaceutical cost management services; medical cost management in the field of pharmaceuticals; business data analyzing and reporting services in the fields of healthcare and pharmaceuticals; business services provided to the healthcare industry, namely, the collection and reporting of data pertaining to pharmaceuticals for business purpose
Pharmacy benefit management services; financial consulting relating to healthcare, namely, developing pricing models to determine reimbursement rates for drugs
Pharmaceutical advice; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical and pharmaceutical consulting services; health care services, namely, disease management programs; medication therapy management in the nature of medication review being medication counseling and medical and pharmaceutical consulting services
What has happened so far
Steps recorded by the USPTO, newest first.
- Teas/email correspondence entered
- Correspondence received in law office
- Teas response to office action received
- Application extension granted/receipt provided
- Application extension to response period - received
- Notification of non-final action e-mailed
- Non-final action e-mailed
- Non-final action written
- Assigned to examiner
- New application office supplied data entered
2 earlier steps on the official record.
About PRICESYNC
Who owns the trademark "PRICESYNC"?
The USPTO trademark "PRICESYNC" (application 99166742) is owned by Prime Therapeutics LLC.
What is the status of "PRICESYNC"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull PRICESYNC and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2abd-8097-7344-a451-86e47b6d090b
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2abd-8097-7344-a451-86e47b6d090b",
"object": "trademark",
"mark_text": "PRICESYNC",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "99166742",
"filing_date": "2025-05-01",
"nice_classes": [
35,
36,
44
],
"owners": [
{
"name": "Prime Therapeutics LLC",
"entity_id": "ent_019eb6fe-75bc-7498-b91a-6bffe9e5b38d"
}
]
}